Gillies and Fre´chet
) 5.7), 3.07 (t, 4H, J ) 6.3), 3.58 (dd, 8H, J ) 11.6, 3.5), 4.00-
4.13 (m, 6H), 4.32-4.37 (m, 8H), 4.54 (dd, 8H, J ) 11.6, 4.2),
4.64 (s, 2H), 5.32 (s, 2H), 5.40 (s, 4H), 7.29-7.32 (m, 12H),
7.37-7.39 (m, 8H). 13C NMR (125 MHz, CDCl3): δ 17.4, 17.78,
17.81, 27.7, 29.7, 36.6, 38.0, 42.6, 42.7, 46.6, 47.0, 50.6, 51.7,
51.9, 63.5, 65.3, 66.1, 73.6, 101.9, 126.3, 128.3, 129.1, 137.9,
158.04, 172.0, 172.3, 173.4. MS calcd [M + Na]+ (C93H123N5-
NaO24): 1717.9. Found: (MALDI-TOF) 1719.1. Anal. Calcd for
26.4, 28.4, 30.0, 40.2, 42.1, 42.2, 46.6, 46.9, 65.0, 65.5, 66.0,
66.1, 66.7, 98.1, 128.2, 128.3, 128.6, 135.6, 158.3, 171.2, 171.9,
172.1, 173.6. MS calcd [M + Na]+ (C63H96NaN2O25): 1304.4.
Found: (MALDI-TOF) 1305.2. Anal. Calcd for
C63H69-
NaN2O25: C, 59.05; H, 7.55; N, 2.19. Found: C, 59.33; H, 7.58;
N, 2.19.
(HO)8-[G-3]-glycin ylu r ea (12). Compound 11b (75 mg, 63
µmol, 1.0 equiv) was dissolved in 2 mL of CH3CN and was
diluted with 1 mL of 20 mM pH 7.0 borate buffer. CAN (5.5
mg, 10 µmol, 0.16 equiv) was added, and the reaction mixture
was heated at 50 °C for 2 h. After cooling the reaction mixture
was partitioned between THF and 0.1 M NaHSO4 in saturated
brine. The organic phase was washed with another portion of
the acidic brine, dried, and evaporated. The product was
purified by passing over a silica plug, using first EtOAc/MeOH
(90/10), followed by EtOAC/MeOH (80/20) to provide 55 mg
(85%) of 12 as a colorless glass. IR (film from THF): 3390,
C
93H123N5O24: C, 65.93; H, 7.31; N, 4.31. Found: C, 65.74; H,
7.27; N, 4.18.
N-(4-Nit r op h en yloxyca r b on yl)b en zyl Glycin a t e (8).
Benzyl glycinate (0.62 g, 3.8 mmol, 1.0 equiv), prepared as
previously reported29 was dissolved in 4 mL of 1:1 CH2Cl2/
pyridine and was added dropwise to a solution of 4-nitrophenyl
chloroformate (2.3 g, 11 mmol, 3 equiv) in 20 mL of CH2Cl2 at
0 °C. After 10 min, the solution was diluted with CH2Cl2 and
washed with 1 M NaHSO4 and brine. The organic phase was
evaporated, and the product was purified by column chroma-
tography using CH2Cl2/hexane (90/10) to elute with excess
4-nitrophenyl chloroformate, followed by CH2Cl2 to elute the
product. The fractions containing product were combined and
washed with 2% Na2CO3 to remove 4-nitrophenol. The organic
phase was dried and evaporated to provide 0.81 g (65%) of 8
as a white solid. Mp: 111-112 °C. IR (film from CH2Cl2):
3315, 3080, 1747, 1714, 1520. 1H NMR (500 MHz, CDCl3): 4.10
(d, 2H, J ) 6.2), 5.21 (s, 2H), 5.91 (t, 3H, J ) 5.6), 7.26-7.29
(m, 2H), 7.33-7.37 (m, 5H), 8.17-8.21 (m, 2H). 13C NMR (125
MHz, CDCl3): 43.0, 67.6, 122.1, 125.2, 128.5, 128.8, 128.8,
1
1735, 1726, 1584. H NMR (500 MHz, MeOD): 1.15 (s, 12H),
1.29 (s, 6H), 1.30 (s, 3H), 1.37-1.41 (m, 4H), 1.48-1.51 (m,
2H), 1.68-1.71 (m, 2H), 3.14 (t, 2H, J ) 7.0), 3.60 (d, 8H, J )
10.7), 3.68 (dd, 8H, J ) 10.9, 2.6), 3.72 (d, 2H, J ) 9.9), 4.16
(t, 2H, J ) 6.6), 4.23-4.33 (m, 12H). 13C NMR (125 MHz,
MeOD): 17.5, 18.3, 18.4, 27.0, 27.7, 29.8, 31.3, 41.2, 45.2, 48.1,
48.2, 51.9, 65.9, 66.3, 66.8, 67.5, 161.3, 173.9, 174.2, 176.1. MS
calcd [M + Na]+ (C44H74NaN2O25): 1054.1. Found: (MALDI-
TOF) 1053.9.
(HO)8-[G-3]-glycin ylu r ea Ben zyl Ester (13). The ester
11a (0.18 g, 0.14 mmol, 1.0 equiv) was dissolved in 2 mL of
CH3CN and was diluted with 1 mL of 20 mM pH 7.0 borate
buffer. CAN (12 mg, 22 µmol, 0.16 equiv) was added, and the
reaction mixture was heated at 50 °C for 2 h. After cooling,
the reaction mixture was partitioned between THF and
saturated brine. The organic phase was washed with another
portion of brine, dried, and evaporated. The product was
purified by passing it over a silica plug, using first EtOAc/
MeOH (90/10), followed by EtOAC/MeOH (80/20) to provide
0.13 g (85%) of 13 as a colorless glass. IR (film from THF):
135.1, 145.0, 153.4, 155.8, 169.5. MS calcd [M
+
H]+
(C16H15N2O6): 331.0930. Found: (HRFAB) 331.0936. Anal.
Calcd for C16H14N2O6: C, 58.21; H, 4.27; N, 8.49. Found: C,
58.48; H, 4.09; N, 8.66.
[3-(6-Hyd r oxyh exyl)u r eid o]a cetic Acid Ben zyl Ester
(9). To a solution of 8 (0.79 g, 2.4 mmol, 1.0 equiv) in 10 mL
of benzene were added 1,6-aminohexanol (0.34 g, 2.9 mmol,
1.2 equiv), DMAP (88 mg, 0.72 mmol, 0.30 equiv), and
diisopropylethylamine (0.46 g, 3.6 mmol, 1.5 equiv). The
reaction mixture was stirred at room temperature for 30 min,
diluted with 50 mL of CH2Cl2, and washed with 1 M NaHSO4,
2% Na2CO3, and saturated brine. The organic phase was dried
and evaporated to give 0.61 g (86%) of 9 as a white solid. Mp:
1
3400, 1737, 1660, 1572. H NMR (400 MHz, MeOD): 1.15 (s,
12H), 1.29 (s, 6H), 1.30 (s, 3H), 1.37-1.42 (m, 4H), 1.47-1.53
(m, 2H), 1.65-1.71 (m, 2H), 3.12-3.17 (m, 2H), 3.60 (d, 8H, J
) 10.9), 3.69 (dd, 8H, J ) 10.9, 2.1), 3.92 (s, 2H), 4.16 (t, 2H,
J ) 6.6), 4.25 (dd, 4H, J ) 11.0, 2.2), 4.29-4.34 (m, 8H), 5.17
(s, 2H), 7.31-7.39 (m, 5H). 13C NMR (100 MHz, MeOD): 17.5,
18.3, 18.4, 26.9, 27.6, 29.7, 31.2, 41.1, 43.0, 48.0, 51.9, 65.9,
66.3, 66.8, 67.4, 67.8, 129.35, 129.40, 129.7, 137.4, 161.1, 172.7,
173.9, 174.1, 176.0. MS calcd [M + Na]+ (C51H80NaN2O25):
1144.2. Found: (MALDI-TOF) 1144.7. Anal. Calcd for
1
75-77 °C. IR (film from CH2Cl2): 3350, 1740, 1648, 1580. H
NMR (500 MHz, CDCl3): 1.27-1.37 (m, 4H), 1.43-1.54 (m,
4H), 2.71 (s, 1H), 3.11-3.15 (m, 2H), 3.56-3.58 (m, 2H), 3.99
(d, 2H, J ) 6.0), 5.13 (s, 2H), 5.35 (t, 3H, J ) 5.5), 5.57 (t, 3H,
J ) 5.55), 7.29-7.35 (m, 5H). 13C NMR (125 MHz, CDCl3):
25.4, 26.5, 30.2, 32.6, 40.4, 42.4, 62.6, 67.1, 128.4, 128.6, 128.8,
135.5, 158.7, 171.7. MS calcd [M + H]+ (C16H25N2O4): 309.1814.
Found: (HRFAB) 309.1820. Anal. Calcd for C16H24N2O4: C,
62.34; H, 7.85; N, 9.08. Found: C, 62.12; H, 8.05; N, 9.08.
C
51H80N2O25: C, 54.63; H, 7.19; N, 2.50. Found: C, 54.46; H,
7.48; N, 2.44.
Oligo(eth ylen e oxid e)-[G-3]-gylcin ylu r ea Ben zyl Ester
(15a ). Compound 13 (79 mg, 70 µmol, 1.0 equiv) was dissolved
in 2 mL of DMF and was diluted with 4 mL of CH2Cl2. The
acid 14 (0.32 g, 1.1 mmol, 16 equiv), prepared as previously
reported,26 was added, followed by DCC (0.29 g, 1.4 mmol, 20
equiv), DMAP (28 mg, 0.23 mmol, 3.2 equiv), and DPTS (72
mg, 0.23 mmol, 3.2 equiv). The reaction mixture was stirred
at room temperature overnight under a nitrogen atmosphere
and then was filtered to remove DCU. The filtrate was diluted
with EtOAc and washed with saturated brine. The organic
phase was dried and evaporated. The resulting residue was
purified by column chromatography using a solvent gradient
from EtOAc/Hex (75/25) to CH2Cl2/MeOH (50/50), yielding 0.14
g (63%) of 15a as a colorless glass. IR (film from CH2Cl2): 3400,
1752, 1685, 1550. 1H NMR (400 MHz, CDCl3): δ 1.15 (s, 18H),
1.19 (s, 3H), 1.23-1.31 (m, 4H), 1.34-1.43 (m, 2H), 1.51-1.59
(m, 2H), 3.03 (m, 2H), 3.28 (s, 24H), 3.44-3.46 (m, 16H), 3.50-
3.56 (m, 48H), 3.60-3.66 (m, 20H), 3.90 (d, 2H, J ) 6), 4.02
(t, 2H, J ) 8.0), 4.14-4.22 (m, 72H), 5.05 (s, 2H), 5.25 (s, 1H),
5.40 (s, 1H), 7.24-7.28 (m, 5H). 13C NMR (100 MHz, CDCl3):
17.4, 17.7, 25.6, 26.3, 28.3, 30.1, 40.0, 42.0, 46.3, 46.5, 46.6,
58.9, 63.9, 65.2, 65.3, 65.5, 66.3, 66.5, 67.7, 67.8, 68.8, 70.42,
70.44, 71.8, 128.1, 128.2, 128.5, 135.5, 158.1, 169.2, 169.6,
(Isopr opyliden e)4-[G-3]-glycin ylu r ea Ben zyl Ester (11a).
The alcohol 9 (0.14 g, 0.48 mmol, 1.0 equiv) and acid 1024 (0.72
g, 0.72 mmol, 1.5 equiv) were dissolved in 10 mL of CH2Cl2.
DMAP (12 mg, 96 µmol, 0.20 equiv) and DPTS (30 mg, 96 µmol,
0.20 equiv) were added, followed by DCC (0.20 g, 0.96 mmol,
2.0 equiv), and the reaction mixture was stirred at room
temperature overnight under a nitrogen atmosphere. The
reaction was filtered to remove the dicyclohexylurea (DCU)
byproduct, and the filtrate was concentrated. The product was
purified by column chromatography using a solvent gradient
from EtOAc/Hex (60/40) to EtOAc/Hex (80/20) to afford 0.55 g
(91%) of 11a as a colorless glass. IR (film from CH2Cl2): 3400,
1753, 1686, 1656, 1562. 1H NMR (500 MHz, CDCl3): δ 1.12
(s, 12H), 1.27 (s, 3H), 1.28 (s, 6H), 1.34 (s, 12H), 1.34-1.38
(m, 4H), 1.41 (s, 12H), 1.45-1.49 (m, 2H), 1.60-1.67 (m, 2H),
3.17-3.21 (m, 2H), 3.62 (dd, 8H, J ) 11.8, 2.4), 4.00 (d, 2H, J
) 5.5), 4.11-4.16 (m, 10H), 4.20-4.34 (m, 12H), 5.14 (s, 2H),
5.35 (t, 1H, J ) 5.5), 5.51 (t, 1H, J ) 5.6), 7.30-7.36 (m, 5H).
13C NMR (125 MHz, CDCl3): 17.6, 17.7, 18.4, 21.6, 25.5, 25.7,
(29) Gray, C. J .; Quibell, M.; J iang, K.-L.; Baggett, N. Synthesis
1991, 2, 141-147.
52 J . Org. Chem., Vol. 69, No. 1, 2004